Circulating Tumor Cell (CTC) Diagnostics

World Market Report

MCP-7869

EXECUTIVE ENGAGEMENTS

POOL

2011
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

362
Interactions with Platform & by Email

PARTICIPANTS

62
Unique # Participated

VALIDATIONS

18
Responses Validated*

COMPANIES

48
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2022

TABLES

122

PAGES

196

EDITION

18

PRICE

USD 5450

CODE

MCP-7869


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

STRONG ACTIVE NICHE TRIVIAL

%

VALIDATED RESEARCH *

S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What's New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Amid the COVID-19 crisis, the global market for Circulating Tumor Cell (CTC) Diagnostics estimated at US$9.4 Billion in the year 2020, is projected to reach a revised size of US$21.1 Billion by 2027, growing at a CAGR of 12.2% over the analysis period 2020-2027. Detection & Enrichment, one of the segments analyzed in the report, is projected to record a 11.7% CAGR and reach US$13.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Analysis segment is readjusted to a revised 14% CAGR for the next 7-year period.
The Circulating Tumor Cell (CTC) Diagnostics market in the U.S. is estimated at US$2.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.7 Billion by the year 2027 trailing a CAGR of 11.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.7% and 10.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.8% CAGR.
In the global Direct Detection segment, USA, Canada, Japan, China and Europe will drive the 10.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$863.8 Million in the year 2020 will reach a projected size of US$1.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.5 Billion by the year 2027.

SELECT PLAYERS

ApoCell, Inc.; Biocep Ltd.; Biocept, Inc.; Biofluidica Microtechnologies LLC; Celltraffix Inc.; Clearbridge Biomedics; Creatv Microtech, Inc.; Cynvenio Biosystems, Inc.; Fluxion Biosciences, Inc.; Ikonisys, Inc.; IVDiagnostics, Inc.; Janssen Diagnostics LLC; QIAGEN Hannover GmbH; Rarecells Sas; Screencell; Stemcell Technologies, Inc.

SEGMENTS

» Technology (Detection & Enrichment, Analysis, Direct Detection) » Specimen (Blood, Bone Marrow, Other Body Fluids) » Application (Research, Clinical / Liquid Biopsy)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Market Outlook
Recent Market Activity
Clinical Relevance of CTCs
CTC Detection - Real-Time 'Liquid Biopsy' Scores Over Surgical Biopsy
Major Challenges in CTC Diagnostics
Need for CTC Enrichment and Popular Methods
CTC Enrichment Techniques
Select Available CTC Detection Technologies
Select CTC Isolation Systems - A Brief Comparison
CTC Identification - Various Approaches
CTC Identification Approaches
List of mRNA Markers for RT-PCR–based Detection of CTCs by Tumor Type
CellSearch System™ - The First FDA Approved Automated Enrichment/Isolation Technique
Rising Incidence of Cancer - An Opportunity Indicator
Cancer Prone Sites based on Age
Circulating Tumor Cell (CTC) Diagnostics – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
ApoCell, Inc. (US)
Biocep Ltd. (Israel)
Biocept, Inc. (US)
Biofluidica Microtechnologies LLC (US)
Celltraffix Inc. (US)
Clearbridge Biomedics (Singapore)
Creatv Microtech, Inc. (US)
Cynvenio Biosystems, Inc. (US)
Epic Biosciences Inc. (US)
Fluxion Biosciences, Inc. (US)
Ikonisys, Inc. (US)
IVDiagnostics, Inc. (US)
Janssen Diagnostics LLC (US)
QIAGEN Hannover GmbH (Germany)
RARECELLS SAS (Italy)
ScreenCell (France)
STEMCELL Technologies, Inc. (Canada)
3. MARKET TRENDS & DRIVERS
Liquid Biopsy - the New Buzzword in Healthcare
Select Companies Active in Cancer Liquid Biopsy
CTCs for Personalized Cancer Treatment
Microfluidic Chip-based Technologies - A Promising Avenue for Cancer Diagnosis
CTC Microdevices Hog the Limelight
Increasing Research Reveal Further Complexities to CTC Composition and Behavior
EpCAM Glycoprotein - Insufficient for CTC Detection
New Isolation Techniques Show Promise in Detecting EpCAM-Negative CTCs
Physical Property-based Enrichment Technologies Lose Fizz
Evidence in Favor CTC Heterogeneity Gains Strength
CTC Clusters Raise Research Interest
Detection of EMTs Gains Precedence in the Backdrop of Recent Research Findings
Limitations of CTC Technology for Point-of-Care Testing
CTC Technologies Offer an Edge over Imaging Tests for Breast Cancer Prognosis
Limited Biomarkers Utilized In CTC Diagnostics - A Threat to Market Growth?
Select Research Findings in Recent Years
Microfluidic Device with Micro-Hall Sensors Detect CTCs with Higher Sensitivity and Specificity
NBiomics Makes its Contribution to CTC Diagnosis
Researchers at University of Michigan Develop Revolutionary Capture CTCs Method
Dean Flow Fractionation to Overcome Limitations Associated with Conventional Biomarker Analysis
Gold Nanoparticles Help in the Detection of CTCs
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Detection & Enrichment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Detection & Enrichment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Detection & Enrichment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Direct Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Direct Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Direct Detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Bone Marrow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Bone Marrow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Bone Marrow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Body Fluids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Body Fluids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Body Fluids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Clinical / Liquid Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Clinical / Liquid Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Clinical / Liquid Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Circulating Tumor Cell (CTC) Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
UNITED STATES
Circulating Tumor Cell (CTC) Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for Detection & Enrichment, Analysis and Direct Detection for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Research and Clinical / Liquid Biopsy for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Percentage Breakdown of Value Sales for Blood, Bone Marrow and Other Body Fluids for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for Detection & Enrichment, Analysis and Direct Detection for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Research and Clinical / Liquid Biopsy for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Percentage Breakdown of Value Sales for Blood, Bone Marrow and Other Body Fluids for the Years 2012, 2021 & 2027
JAPAN
Circulating Tumor Cell (CTC) Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for Detection & Enrichment, Analysis and Direct Detection for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Research and Clinical / Liquid Biopsy for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Percentage Breakdown of Value Sales for Blood, Bone Marrow and Other Body Fluids for the Years 2012, 2021 & 2027
CHINA
Circulating Tumor Cell (CTC) Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for Detection & Enrichment, Analysis and Direct Detection for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Research and Clinical / Liquid Biopsy for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Percentage Breakdown of Value Sales for Blood, Bone Marrow and Other Body Fluids for the Years 2012, 2021 & 2027
EUROPE
Circulating Tumor Cell (CTC) Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for Detection & Enrichment, Analysis and Direct Detection for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Research and Clinical / Liquid Biopsy for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Percentage Breakdown of Value Sales for Blood, Bone Marrow and Other Body Fluids for the Years 2012, 2021 & 2027
FRANCE
Circulating Tumor Cell (CTC) Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for Detection & Enrichment, Analysis and Direct Detection for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Research and Clinical / Liquid Biopsy for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Percentage Breakdown of Value Sales for Blood, Bone Marrow and Other Body Fluids for the Years 2012, 2021 & 2027
GERMANY
Circulating Tumor Cell (CTC) Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for Detection & Enrichment, Analysis and Direct Detection for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Research and Clinical / Liquid Biopsy for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Percentage Breakdown of Value Sales for Blood, Bone Marrow and Other Body Fluids for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for Detection & Enrichment, Analysis and Direct Detection for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Research and Clinical / Liquid Biopsy for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Percentage Breakdown of Value Sales for Blood, Bone Marrow and Other Body Fluids for the Years 2012, 2021 & 2027
UNITED KINGDOM
Circulating Tumor Cell (CTC) Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for Detection & Enrichment, Analysis and Direct Detection for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Research and Clinical / Liquid Biopsy for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Percentage Breakdown of Value Sales for Blood, Bone Marrow and Other Body Fluids for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for Detection & Enrichment, Analysis and Direct Detection for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Research and Clinical / Liquid Biopsy for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Percentage Breakdown of Value Sales for Blood, Bone Marrow and Other Body Fluids for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Circulating Tumor Cell (CTC) Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for Detection & Enrichment, Analysis and Direct Detection for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Research and Clinical / Liquid Biopsy for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Percentage Breakdown of Value Sales for Blood, Bone Marrow and Other Body Fluids for the Years 2012, 2021 & 2027
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Technology - Detection & Enrichment, Analysis and Direct Detection Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Technology - Percentage Breakdown of Value Sales for Detection & Enrichment, Analysis and Direct Detection for the Years 2012, 2021 & 2027
Rest of World Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Application - Research and Clinical / Liquid Biopsy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Application - Percentage Breakdown of Value Sales for Research and Clinical / Liquid Biopsy for the Years 2012, 2021 & 2027
Rest of World Recent Past, Current & Future Analysis for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Blood, Bone Marrow and Other Body Fluids Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Circulating Tumor Cell (CTC) Diagnostics by Specimen - Percentage Breakdown of Value Sales for Blood, Bone Marrow and Other Body Fluids for the Years 2012, 2021 & 2027
Total Companies Profiled: 48

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com